| Date Filed | Type | Description |
| 08/15/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.2% stake in IO Biotech, Inc. |
| 08/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 6.1% stake in IO Biotech, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.7% stake in Y-mAbs Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.6% stake in Harmony Biosciences Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.1% stake in Ambrx Biopharma Inc. |
| 02/14/2023 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 02/09/2023 |
3
| HBM Healthcare Investments (Cayman) Ltd. (10% Owner) has filed a Form 3 on Mineralys Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 4% stake in BioAtla, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 6.9% stake in Ambrx Biopharma Inc. |
| 02/11/2022 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.4% stake in IO Biotech, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 0% stake in Galecto, Inc. |
| 02/11/2022 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 7.8% stake in Harmony Biosciences Holdings, Inc. |
| 02/07/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/12/2021 |
4
| HBM Healthcare Investments (Cayman) Ltd. (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,365,545 shares
@ $0
Bought 325,000 shares
@ $14, valued at
$4.6M
Converted 188,168 preferred shares
@ $0 |
|
| 11/04/2021 |
3
| HBM Healthcare Investments (Cayman) Ltd. (10% Owner) has filed a Form 3 on IO Biotech, Inc. |
| 07/02/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 6.7% stake in Ambrx Biopharma, Inc. |
| 05/05/2021 |
4
| HBM Healthcare Investments (Cayman) Ltd. (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Converted 625,995 shares
@ $0
Converted 5,426,819 preferred shares
@ $0 |
|
| 04/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/22/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 10% stake in Longboard Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.2% stake in Harmony Biosciences Holdings, Inc. |
| 02/12/2021 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 5.3% stake in Y-mAbs Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.2% stake in Galecto, Inc. |
| 12/28/2020 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 8.8% stake in BioAtla, Inc. |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/01/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 3.5% stake in Principia Biopharma Inc. |
| 02/14/2019 |
SC 13G/A
| HBM Healthcare Investments Ltd. reports a 8.2% stake in Y-mAbs Therapeutics, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/01/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 9% stake in Y-mAbs Therapeutics, Inc. |
| 09/27/2018 |
SC 13G
| HBM Healthcare Investments Ltd. reports a 5.3% stake in Principia Biopharma Inc. |
|